A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS
International Journal of Biological Studies · 2022
DOI: 10.47941/ijbs.900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Studies, 2022. Verfasst von Dennis Amboja.
Abstract (Originalsprache)
Purpose
The study aimed to assess the total lymphocyte count and CD4 count in HIV affected patients. Methodology: The approach we used in this study was to gather and analyze a wide range of research articles.
Findings
Worldwide estimates of people living with Human Immunodeficiency Virus was approximately 32 million in 2007 with thousands of people getting infected every day. Most people living with HIV are from developing countries with less than 5% receiving antiretroviral therapy. In 2009, an estimated 2.6 million people became infected out of which approximately 1.8 million were from sub-Saharan Africa. The initiation of antiretroviral therapy is based on CD4 counts of less than 350 cells/mm3 according to the World Health Organization (WHO) and Centre for Disease Control (CDC). The determination of CD4 count however in resource-limited localities is difficult. A total lymphocyte count (TLC) of
Zitieren
APA
Amboja, D. (2022). A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS. International Journal of Biological Studies. https://doi.org/10.47941/ijbs.900
Vancouver
Amboja D. A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS. International Journal of Biological Studies. 2022. doi:10.47941/ijbs.900
BibTeX
@article{Amboja2022,
author = {Amboja, Dennis},
title = {A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS},
journal = {International Journal of Biological Studies},
year = {2022},
doi = {10.47941/ijbs.900}
}
EUVIMED